# ADA Linagliptin in Long Term Care

> **NCT02061969** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 140 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** linagliptin
- **DRUG:** insulin glargine

## Key facts

- **NCT ID:** NCT02061969
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-25
- **Primary completion:** 2017-04-10
- **Final completion:** 2017-04-10
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2018-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061969, "ADA Linagliptin in Long Term Care". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02061969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*